Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-050787
Filing Date
2024-12-11
Accepted
2024-12-11 16:36:51
Documents
1
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1733953005.html 4  
1 FORM 4 wk-form4_1733953005.xml 4 3352
  Complete submission text file 0001628280-24-050787.txt   4786
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O YEXT, INC. 61 NINTH STREET NEW YORK NY 10011
Business Address
Davis Mark Steven (Reporting) CIK: 0002024613 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 241541990